Investments

Funds will expand the U.S. commercial launch of an initial product in the rotator cuff repair market....

The company completed a $11.5 million funding round to progress a clinical study of LDGraft, a bone graft substitute for...

Funds will support commercial expansion and clinical activities for the Bridge-Enhanced ACL Restoration (BEAR) Implant....

Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology....

Proceeds will accelerate aprevo personalized lumbar and cervical patient-specific interbody fusion devices....

The company will be funded to complete product development and an initial commercial launch of a functional MTP implant that...

Bone Biologics is focusing development of a bone graft substitute for bone regeneration in spinal fusion procedures, while additionally having...

Symani can support challenging and complex trauma procedures with an increased degree of precision and control in an optimized work...

Pixee closed a $15 million capital raising to accelerate commercialization in the U.S. and launch next-generation products. ...

While economic pressure slowed orthopedic funding in recent years, there is ample capital for enabling technology companies....